CHECKOUT

Select a product to checkout

● E-E-A-T & Trust Framework

Editorial Policy & Scientific Standards

Our rigorous methodology for producing evidence-grounded research guides, validating analytical documentation, and maintaining scientific integrity.

1. Purpose & Scope of Research Content

Peptides Hub Australia publishes scientific guides, analytical chemistry overviews, and compound summaries to inform the laboratory research community, academic investigators, and analytical chemists.

Strict Non-Medical Stance: Our educational resources do NOT provide medical advice, diagnosis, treatment plans, human dosing instructions, or clinical protocols. All compounds referenced are investigational or research-grade analytical standards intended solely for in-vitro laboratory experimentation.

2. Source Selection & Evidence Hierarchy

We adhere to a strict hierarchy of evidence to prevent misinformation and maintain objective scientific rigor:

Primary Source Priority (Required)
  • Peer-Reviewed Journals: Publications in NEJM, The Lancet, Cell Metabolism, Nature, JACS.
  • Regulatory Agencies: United States FDA, Australian TGA, European Medicines Agency (EMA).
  • Trial Registries: ClinicalTrials.gov, ANZCTR official registration IDs.
  • Innovator Pipeline Disclosures: Direct corporate science updates (e.g. Eli Lilly).
Prohibited Sources (Strictly Excluded)
  • Unverified online forums, blogs, or social media discussions.
  • Commercial peptide vendors without transparent analytical test reports.
  • Anecdotal user testimonials or self-administration logs.
  • Promotional marketing claims lacking peer-reviewed citations.

3. Review Cycles & Date Sensitivity

Because investigational peptide research (such as retatrutide Phase 3 trials) evolves rapidly, all scientific guides feature clearly visible metadata:

Published Date
Initial Release
Last Reviewed
September 2026
Updated Date
Trial Progress Updates

Our scientific team conducts recurring audits to integrate new Phase 3 data, updated chromatographic guidelines, or regulatory status changes immediately upon publication.

4. Analytical Integrity & Correction Policy

  • No Fabricated Laboratory Results: We strictly prohibit transforming specification thresholds into measured results or publishing non-authentic data. Every batch is represented by its genuine third-party PDF testing report.
  • Transparent Corrections: If an error in molecular notation, trial identifier, or citation is identified, our editorial staff issues a transparent correction stating the nature of the update and the timestamp.
  • Inquiries & Peer Feedback: Scientific researchers and laboratory personnel are encouraged to submit technical feedback or citation reviews via our contact portal.
VIEW SCIENTIFIC RESEARCH SOURCES → RETATRUTIDE RESEARCH GUIDE